Evidence map›Paper›PMID 36750100›Full record

ArticleImmunity2023

Circumvention of luteolysis reveals parturition pathways in mice dependent upon innate type 2 immunity.

Johan Siewiera, Tara I McIntyre, Kelly M Cautivo, Karim Mahiddine, Damon Rideaux, Ari B Molofsky, Adrian Erlebacher

Open access · greenAbstract read
In one paragraph

Article in Immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Immune system influence on physiology.Science (New York, N.Y.) · 2025
    Review
  5. Innate Lymphoid Cells in Reproductive Health and Disease.European journal of immunology · 2025
    Review
  6. Article
  7. The hormonal control of parturition.Physiological reviews · 2024
    Review
  8. Article
  9. Human embryo implantation.Development (Cambridge, England) · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Johan SiewieraDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Tara I McIntyreBiomedical Sciences Program, University of California, San Francisco, San Francisco, CA 94143, USA.
Kelly M CautivoDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Karim MahiddineDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Damon RideauxDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Ari B MolofskyDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Biomedical Sciences Program, University of California, San Francisco, San Francisco, CA 94143, USA; Bakar ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA.
Adrian ErlebacherDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Biomedical Sciences Program, University of California, San Francisco, San Francisco, CA 94143, USA; Bakar ImmunoX Initiative, University of California, San Francisco, San Francisco, CA 94143, USA; Center for Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: adrian.erlebacher@ucsf.edu.
University of California, San Francisco · US

Funding

MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
The IL-33/ILC2 axis in parturitionR01AI150191 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ERLEBACHER, ADRIAN · 2020 to 2024
$3.2M
Epigenetic regulation of decidual inflammationR01AI106745 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ERLEBACHER, ADRIAN · 2013 to 2016
$1.8M
NIAID NIH HHS R01 AI106745NIAID NIH HHS R01 AI150191NIAID NIH HHS T32 AI007334
6 · The paper itself

Abstract

Although mice normally enter labor when their ovaries stop producing progesterone (luteolysis), parturition can also be triggered in this species through uterus-intrinsic pathways potentially analogous to the ones that trigger parturition in humans. Such pathways, however, remain largely undefined in both species. Here, we report that mice deficient in innate type 2 immunity experienced profound parturition delays when manipulated endocrinologically to circumvent luteolysis, thus obliging them to enter labor through uterus-intrinsic pathways. We found that these pathways were in part driven by the alarmin IL-33 produced by uterine interstitial fibroblasts. We also implicated important roles for uterine group 2 innate lymphoid cells, which demonstrated IL-33-dependent activation prior to labor onset, and eosinophils, which displayed evidence of elevated turnover in the prepartum uterus. These findings reveal a role for innate type 2 immunity in controlling the timing of labor onset through a cascade potentially relevant to human parturition.

Indexed as

Interleukin-33LuteolysisAnimalsFemaleHumansImmunity, InnateLymphocytesMiceMyometriumParturitionPregnancyInterleukin-33eosinophilsgroup 2 innate lymphoid cellsIL-33myometriumparturitionpreterm labor

Identifiers

PMID36750100
PMCPMC10023352
OpenAlexW36750100

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.